3-Cyclopentylacrylonitrile

3-Cyclopentylacrylonitrile
Product Description

  • 是治疗骨髓纤维化和白癜风药物鲁索替尼(Ruxolitinib)的关键中间体。
  • It is a key intermediate for ruxolitinib, a drug used in the treatment of myelofibrosis and vitiligo.

Read more Show less

Henan Chongyi Biomedicine Co., Ltd

  • Country/Region:
    China
  • On CPHI since:
    2025
  • Certificates:
    2
  • Employees:
    50 - 99
Company types
CMO/CDMO
Contract Service
Distributor/Import Export
Manufacturer/Innovator
Primary activities
Chemical Development
Contract Manufacturer
Fine Chemicals Company
Intermediates Manufacturer
Technology
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    16377-93-4
  • Details
    • 是治疗骨髓纤维化和白癜风药物鲁索替尼(Ruxolitinib)的关键中间体。
    • It is a key intermediate for ruxolitinib, a drug used in the treatment of myelofibrosis and vitiligo.
  • Selling Points
    Product Performance; Quality Service; Sustainability
  • Measured In
    gram; kilogram
More specifications Fewer specifications

Henan Chongyi Biomedicine Co., Ltd

  • Country/Region:
    China
  • On CPHI since:
    2025
  • Certificates:
    2
  • Employees:
    50 - 99
Company types
CMO/CDMO
Contract Service
Distributor/Import Export
Manufacturer/Innovator
Primary activities
Chemical Development
Contract Manufacturer
Fine Chemicals Company
Intermediates Manufacturer
Technology
View company profile

More Products from Henan Chongyi Biomedicine Co., Ltd (2)

Henan Chongyi Biomedicine Co., Ltd resources (1)

  • CPHI Frankfurt 2025

    News CPHI Frankfurt 2025

    • Both No.:  11.1H 37-2
    • Start date28 Oct 2025
    • End date30 Oct 2025

    26 Oct 2025